MDWD241220P17500
- 0.75
- 0.000.00%
MediWound Newsroom
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30
Strategic Growth and Market Potential Drive Buy Rating for MediWound Despite Revenue Decline
Urban Outfitters To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Wednesday
MediWound Analyst Ratings
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $25
Express News | Mediwound Ltd. : H.c. Wainwright Cuts Target Price to $25 From $28
TD Cowen Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25
MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript
MediWound Advances With FDA Approval and New Funding
MediWound Ltd. Advances Development With EscharEx IND Submission Planned for Year-End and NexoBrid FDA Pediatric Approval
MediWound Q3 2024 GAAP EPS $(0.98) Misses $(0.45) Estimate, Sales $4.36M Miss $6.01M Estimate
MediWound | 6-K: Report of foreign private issuer (related to financial reporting)
Earnings Flash (MDWD) MEDIWOUND Posts Q3 Revenue $4.4M, Vs. Street Est of $6.0M
MediWound Sees FY24 Rev $20M >MDWD
Express News | Mediwound Q3 Adjusted Ebitda USD -3.7 Million
Express News | Mediwound Q3 Net Income USD -10.3 Million
Express News | Mediwound Q3 Gross Profit USD 700 Thousand
Press Release: MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update
MediWound 3Q Loss/Shr 98c >MDWD
Earnings Scheduled For November 26, 2024